BioLife Solutions, Inc. (BLFS)
-OTC Markets 0.32 
0.02(5.88%) 9:41AM EDT
| Prev Close: | 0.34 |
|---|
| Open: | 0.32 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.43 |
|---|
| Next Earnings Date: | 12-Aug-13 |
|---|
| Day's Range: | 0.32 - 0.32 |
|---|
| 52wk Range: | 0.07 - 0.47 |
|---|
| Volume: | 200 |
|---|
| Avg Vol (3m): | 30,348 |
|---|
| Market Cap: | 22.41M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.02 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine CongressPR Newswire(Thu, May 23)
- BIOLIFE SOLUTIONS INC FinancialsEDGAR Online Financials(Tue, May 21)
- BioLife Has More Room To Runat Seeking Alpha(Fri, May 17)
- BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013PR Newswire(Tue, May 14)
- BIOLIFE SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Tue, May 14)
- /C O R R E C T I O N -- BioLife Solutions, Inc./PR Newswire(Mon, May 6)
- BioLife Solutions Announces License AgreementPR Newswire(Thu, May 2)
- BioLife Solutions: Long-Term Potential Is Intact As Growth Continuesat Seeking Alpha(Thu, Apr 11)
- New Revenue Record, Strong 2013 GuidanceZacks Small Cap Research(Tue, Apr 2)
- BioLife Solutions Announces 2012 Full Year Results; 10th Consecutive Quarter of Record RevenuePR Newswire(Mon, Apr 1)
- BIOLIFE SOLUTIONS INC Files SEC form 10-K, Annual ReportEDGAR Online(Fri, Mar 29)
- BIOLIFE SOLUTIONS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, FinancEDGAR Online(Mon, Feb 4)
- BioLife Solutions Appoints Rick Stewart To Board of DirectorsPR Newswire(Mon, Feb 4)
- BIOLIFE SOLUTIONS INC Files SEC form 8-K, Other EventsEDGAR Online(Tue, Jan 8)
- BLFS: Revenue Upside Surprise, Again...Zacks(Mon, Jan 7)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 3.41 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
BioLife Solutions, Inc., a life sciences tools provider, develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells, tissues, and organs.
View More